<DOC>
	<DOCNO>NCT00003834</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient liver metastasis colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy treatment oxaliplatin , fluorouracil , leucovorin calcium term resectability rate patient unresectable advanced colorectal carcinoma confine liver . II . Assess regimen term response rate , toxicity , overall survival patient . OUTLINE : Patients receive oxaliplatin IV 2 hour day 1 , leucovorin calcium IV 2 hour fluorouracil IV bolus , follow fluorouracil IV 22 hour day 1 2 . Courses repeat every 2 week . Patients stable disease continue treatment absence disease progression unacceptable toxicity disease resectable . Patients achieve complete response ( CR ) , partial response ( PR ) unresectable disease , PR surgical candidate continue treatment absence disease progression unacceptable toxicity . Patients demonstrate response treat best response disease deem resectable . Patients achieve CR PR resect may receive 2 4 additional course therapy discretion investigator . Patients follow every 3 month 1 year every 6 month 2 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : History carcinoma colon rectum primary site completely resect Measurable evaluable unresectable liver metastases one following : Involvement 3 major hepatic vein , portal vein bifurcation , retrohepatic vena cava Involvement main right main leave portal vein main hepatic vein opposite lobe Disease require right leave trisegmentectomy Six metastatic lesion distribute diffusely lobes liver PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin normal SGOT great 3 time upper limit normal ( ULN ) No chronic hepatic disease ( e.g. , chronic active hepatitis , cirrhosis ) Renal : Creatinine great 1.5 time ULN Cardiovascular : No history myocardial infarction within past 6 month No congestive heart failure Other : No malignancy within past 5 year except basal cell squamous cell skin cancer carcinoma situ organ tumor associate less 10 % probability death malignant disease within 5 year diagnosis Adequate oral nutrition include estimate intake least 1,500 calorie per day No severe anorexia frequent nausea and/or vomit Able withstand major operative procedure No neuropathy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent immunotherapy Concurrent filgrastim epoetin alfa allow Chemotherapy : At least one year since prior adjuvant systemic fluorouracil without levamisole leucovorin No prior systemic hepatic artery infusion chemotherapy metastatic disease No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy liver At least one year since radiotherapy great 25 % bone marrow No concurrent radiotherapy Surgery : At least 21 day since abdominal exploration without intestinal resection Other : Oral cryotherapy allow day 2 course</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>liver metastasis</keyword>
</DOC>